Switch to:
Novo Nordisk A/S  (NYSE:NVO) Pre-Tax Income: \$7,184 Mil (TTM As of Jun. 2017)

Pretax income is the income that a company earns before paying income taxes. Novo Nordisk A/S's pretax income for the three months ended in Jun. 2017 was \$1,910 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2017 was \$7,184 Mil. Novo Nordisk A/S's pretax margin was 44.15%.

During the past 13 years, Novo Nordisk A/S's highest Pretax Margin was 42.81%. The lowest was 26.22%. And the median was 34.35%.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Novo Nordisk A/S Annual Data

 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Pre-Tax Income 4,890.79 5,979.46 5,649.62 6,345.10 6,777.55

Novo Nordisk A/S Quarterly Data

 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Pre-Tax Income 1,903.34 1,852.84 1,551.53 1,869.65 1,909.73

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Calculation

This is the income that a company earns before paying income taxes.

Novo Nordisk A/S's Pretax Income for the fiscal year that ended in Dec. 2016 is calculated as

 Pretax Income = Operating Income + Non-Recurring Items + Interest Expense + Interest Income + Other = 6867.44937893 + -88.0551301685 + -9.21672054903 + 7.37337643923 + 9.09494701773E-13 = 6,778

Novo Nordisk A/S's Pretax Income for the quarter that ended in Jun. 2017 is calculated as

 Pretax Income = Operating Income + Non-Recurring Items + Interest Expense + Interest Income + Other = 2021.96275093 + 0 + -175.822847907 + 63.5922843376 + -2.27373675443E-13 = 1,910

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2017 was 1852.83928302 (Sep. 2016 ) + 1551.52855765 (Dec. 2016 ) + 1869.65335787 (Mar. 2017 ) + 1909.73218736 (Jun. 2017 ) = \$7,184 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

Novo Nordisk A/S's Pretax Margin for the quarter that ended in Jun. 2017 is calculated as

 Pretax Margin = Pretax Income / Revenue = 1909.73218736 / 4325.78584052 = 44.15%

During the past 13 years, Novo Nordisk A/S's highest Pretax Margin was 42.81%. The lowest was 26.22%. And the median was 34.35%.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Related Terms

From the Internet

###### Impax Laboratories and Amneal Pharmaceuticals Agree to Merge

- Zacks 2017-10-18 09:17:00

###### Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals

- Zacks 2017-10-18 08:55:00

###### Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks

- Zacks 2017-10-17 14:55:00

###### Sanofi/Regeneron's Dupixent Succeeds in Phase II Study

- Zacks 2017-10-17 09:48:00

###### Immune Design's Sarcoma Candidate to Enter Phase III in 2018

- Zacks 2017-10-17 09:04:00

###### Bristol-Myers Gets Priority Review for Opdivo Label Expansion

- Zacks 2017-10-17 08:49:00

###### Glaxo's Shingles Vaccine Shingrix Gets Approval in Canada

- Zacks 2017-10-16 17:07:00